Articles

Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia

Université Pierre et Marie Curie, Paris, France;INSERM, UMRs 938, Paris, France;Service d’Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, APHP, Paris, France;CHRU Hôtel-Dieu, Nantes, France
Université Pierre et Marie Curie, Paris, France;INSERM, UMRs 938, Paris, France;Service d’Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, APHP, Paris, France
University Hospital Leuven, Leuven, Belgium
Hôpital Saint Louis, Paris, France
Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
Helsinki University Central Hospital, Finland
University of Freiburg Medical Center, Germany
Lund University Hospital, Sweden
University Hospital Hamburg-Eppendorf, Hamburg, Germany
VU University Medical Center, Amsterdam, The Netherlands
Queen Elizabeth Hospital, Birmingham, UK
CHRU Lille, France
Ankara University, Faculty of Medicine, Ankara, Turkey
Nottingham University Hospital, Nottingham, UK
King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
The Royal Marsden NHS Foundation Trust, London, UK
Chaim Sheba Medical Center, Tel Hasomer, Israel
Goethe-University Frankfurt, Germany
Erasmus Medical Center–Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
Hospital Clinic Institut d’investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain
Université Pierre et Marie Curie, Paris, France;INSERM, UMRs 938, Paris, France;Service d’Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, APHP, Paris, France
Vol. 100 No. 3 (2015): March, 2015 https://doi.org/10.3324/haematol.2014.116954